Company · Ownership research

Aardvark Therapeutics, Inc. AARD

CIK 0001774857

Form 4 transactions dated Oct 1, 2023 to Oct 15, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through Sep 11, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $23.87M
Sold: $394.96K

Oct 1, 2023 – Sep 11, 2026
Available records · partial months are marked ·

Insiders in this window

202510 of 12 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 11, 2025	Sun Nelson Chief Financial Officer	Purchase	$43.20K 3,000 shares bought	2.84% added Direct holding	▾
Dec 11, 2025	Lee Tien-Li Chief Executive Officer · Director · 10% owner	Purchase	$101.39K 7,000 shares bought	0.45% added Direct holding	▾
Sep 15, 2025	Lee Tien-Li Chief Executive Officer · Director · 10% owner	Purchase	$96.62K 10,000 shares bought	0.65% added Direct holding	▾
Sep 12, 2025	Lee Tien-Li Chief Executive Officer · Director · 10% owner	Purchase	$42.52K 5,000 shares bought	0.33% added Direct holding	▾
Sep 11, 2025	Lee Tien-Li Chief Executive Officer · Director · 10% owner	Purchase	$46.93K 6,000 shares bought	0.39% added Direct holding	▾
Sep 10, 2025	Lee Tien-Li Chief Executive Officer · Director · 10% owner	Purchase	$71.21K 9,000 shares bought	0.59% added Direct holding	▾
Sep 9, 2025	Sun Nelson Chief Financial Officer	Purchase	$48.44K 6,000 shares bought	6.03% added Direct holding	▾
Feb 14, 2025	Cui Xiangmin · Decheng Capital Global Life Sciences Fund IV, L.P. · Decheng Capital Management IV (Cayman), LLC · Decheng Capital Global Healthcare Fund (Master), LP · Decheng Capital Global Healthcare GP, LLC 10% owner	Purchase	$10.00M 625,000 shares bought	Unavailable Indirect holding	▾
Feb 14, 2025	Cui Xiangmin · Decheng Capital Global Life Sciences Fund IV, L.P. · Decheng Capital Management IV (Cayman), LLC · Decheng Capital Global Healthcare Fund (Master), LP · Decheng Capital Global Healthcare GP, LLC 10% owner	Purchase	$10.00M 625,000 shares bought	Unavailable Indirect holding	▾
Feb 14, 2025	Lee Tien-Li Chief Executive Officer · Director · 10% owner	Purchase	$264.67K 16,542 shares bought	1.12% added Direct holding	▾

Showing 12 / 12 record groups in 2025. The complete set is available through the API.

Aardvark Therapeutics, Inc. · AARD

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 12 of 12 purchase / sale groups and 29 of 29 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"AARD","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.